{
  "trial_id": "NCT02467751",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Polycystic Ovary Syndrome",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "body mass index of 18 to 29.9",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "without contraceptive use",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Hypothyroidism",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "hyperprolactinaemia (defined as serum prolactin levels greater than 25 ng/mL)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Cushing's syndrome",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Nonclassical congenital adrenal hyperplasia (defined as serum 17-hydroxyprogesterone levels greater than 1.2 and 5.2 ng/mL in the follicular and luteal phase, respectively) and current or previous (within the last three months) use of oral contraceptives and other hormonal",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Antidiabetic and antiobesity drugs",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "A 3-day-old female infant with jaundice, born at 34w of gestation. Laboratory results show elevated liver enzymes.",
  "_meta": {
    "topic_id": "73",
    "trial_id": "NCT02467751",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}